z-logo
open-access-imgOpen Access
COMPARATIVE PHARMACOECONOMIC ANALYSIS OF LONG-ACTING LANREOTIDE USED IN ACROMEGALY THERAPY WITHIN CONDITIONS OF THE RUSSIAN FEDERATION HEALTH CARE SYSTEM
Author(s) -
I. Krysanov,
Ekaterina Makarova,
V. Ermakova
Publication year - 2022
Publication title -
farmaciâ i farmakologiâ
Language(s) - English
Resource type - Journals
eISSN - 2413-2241
pISSN - 2307-9266
DOI - 10.19163/2307-9266-2022-10-2-164-173
Subject(s) - lanreotide , acromegaly , octreotide , medicine , pharmacoeconomics , pituitary tumors , pharmacotherapy , cost effectiveness analysis , indirect costs , surgery , intensive care medicine , cost effectiveness , somatostatin , growth hormone , accounting , economics , hormone , risk analysis (engineering)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here